Pfizer Australia

Pfizer Australia, established in 1956, is a significant player in the Australian pharmaceutical and healthcare sector. The company specializes in the manufacturing of critical therapeutic products and vaccines, essential for the medical industry. These vital medical supplies are distributed and utilized across hospitals and pharmacies throughout Australia, underscoring Pfizer Australia's role in public health infrastructure. Operating within the broader biopharmaceutical landscape, the company contributes to the availability of advanced medical treatments and preventative health solutions nationwide.

With a robust operational footprint, Pfizer Australia maintains facilities across multiple Australian cities, including its headquarters in Sydney, New South Wales. The company actively fosters innovation through strategic partnerships with various research and academic institutions, aiming to advance medical science within the region. Employing between 500 and 1,000 professionals, Pfizer Australia leverages its dedicated workforce to ensure the quality and efficacy of its products. To learn more about the individuals driving these efforts, one can Meet Pfizer Australia's team. The company's commitment extends to ensuring widespread access to its pharmaceutical offerings.

Pfizer Australia operates within a dynamic and competitive market, facing established pharmaceutical entities. Its revenue stands at $236.7M, reflecting its substantial market presence and operational scale. The company's biopharmaceutical products are integral to patient care, supporting healthcare providers in delivering effective treatments. Through its manufacturing capabilities and strategic collaborations, Pfizer Australia continues to contribute to the nation's healthcare ecosystem, focusing on innovation and the reliable supply of essential medicines and vaccines.